European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Life & Brain GmbH, Bonn, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Life & Brain GmbH

Identification

Ut
District Court of Bonn HRB 10089
EUID
DER3201.HRB10089

Address

Venusberg-Campus 1, 53127 Bonn, Germany

Corporate purpose

Is the research of diseases of the nervous system and other organs as well as the further development of research results in this field for marketable, biomedical applications.

Financials

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Publications

29 Jan 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023
14 Jun 2024
Patent: Modular Tray Unit and Modular Unit for Incubator, and Incubator Using IT, and Incubator
12 Mar 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
3 May 2023
Share­holder agreement
5 Apr 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
9 Mar 2023
Original document: “Liste der Gesellschafter“
15 Feb 2023
Original document: “Liste der Gesellschafter“
15 Feb 2023
Original document: “Gesellschaftsvertrag / Satzung / Statut“
16 Dec 2022
Managing Director: Per Hoffmann
1 Jun 2022 via De Montfort University
EU funding (€1,235,884): Reducing the impact of major environmental challenges on mental health
17 May 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
24 Mar 2021
Annual report for the year ending 31/12/2019
10 Mar 2021
Patent: Up-Scaled Production of Microglia-Like/-Precursor Cells and Macrophage Cells Using Mesh Macrocarriers
19 Jan 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
20 Aug 2020
Patent: Rapid Production of Human Neuronal Cultures with Single Cell Resolution
19 Feb 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
1 Jan 2020 in Hor
EU funding (€300,000): Novel Strategies for Cell-based Neural Reconstruction
24 Oct 2019
Address
30 Aug 2019
Annual report for the year ending 31/12/2017
24 Apr 2019
Patent: Methods for Establishing a Clinical Prognosis of Diseases Associated with the Formation of Aggregates of Abeta1-42
5 Mar 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
13 Jun 2018
Patent: Glioblastoma Inhibiting Compounds and Their USE
9 May 2018
Original document: “Liste der Gesellschafter“
8 Feb 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
26 Jul 2017
Patent: Promotion of Neuronal Integration in Neural Stem Cell Grafts
7 Jun 2017
Authorized signatory (ppa): Ira Herrmann
1 Apr 2017 in Hor
EU funding (€443,000): Modelling Neuron-Glia Networks into a drug discovery platform for Pain Efficacious Treatments - Sofia ref.: 116072
3 Mar 2017
Word figurative mark: “STEMCELLFACTORY“
1 Feb 2017 in Fk
Public funding (€154,458): Neuro2D3 - Standardized systems for modeling late-onset neurological diseases and drug screening in 2D and 3D cultures - TP2
5 Jan 2017
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
2 Nov 2016
Patent: Therapeutic Delivery of Adenosine Into a Tissue
1 Nov 2016 in Hor
EU funding (€451,250): Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976
4 Oct 2016
Wordmark: “STEMCELLFACTORY“
15 Feb 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
1 Jan 2016 in Hor
EU funding (€300,000): Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders
23 Nov 2015
No longer Authorized signatory (ppa) (1)
27 Aug 2015
Wordmark: “SmartCells“
1 May 2015
Patent: In-Vivo Stimulations-Messsonde
1 May 2015 in Fk
Public funding (€117,755): Competence Cluster Nutrition Research: DietBB - From Epidemiology to Evidence-Based Communication, Life & Brain GmbH
8 Apr 2015
No longer Managing Director (1)
1 Apr 2015
Managing Director: Markus Nöthen · No longer Managing Director (1)
23 Jan 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
1 Jan 2015 in Hor
EU funding: European Consortium for Communicating Stem Cell Research
24 Feb 2014
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
19 Feb 2014
Patent: Androgenetic Alopecia
1 Nov 2013 in Fts
EU funding (€400,074): Epitarget
1 Oct 2013 in Fts
EU funding (€686,598): Imagemend
6 Aug 2013
Patent: Niclosamide and ITS Derivatives for USE in the Treatment of Solid Tumors
31 Jul 2013
Patent: Method for Obtaining Human Microglial Precursor Cells From Pluripotent Stem Cells
12 Jun 2013
Patent: Microglial Precursor Cells for the Treatment of Malignant Neoplasms of the Central Nervous System
15 Jan 2013
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
20 Dec 2012
Patent: Glioblastom-Hemmende Verbindungen und Ihre Verwendung
20 Dec 2012
Patent: Glioblastom-Hemmende Verbindungen und Ihre Verwendung
20 Dec 2012
Patent: Glioblastom-Hemmende Verbindungen und Ihre Verwendung
17 Dec 2012
Share­holder agreement
3 Dec 2012
Share­holder agreement
19 Nov 2012
Original document: “Gesellschaftsvertrag / Satzung / Statut“
6 Aug 2012
Patent: Niclosamide and ITS Derivatives for USE in the Treatment of Solid Tumors
1 Jul 2012 in Fk
Public funding (€113,599): Laser-induced, nanoparticle-mediated selective cell elimination and modulation (LAND-CEM) sub-projects: Integration of laser-based technologies for purification and …
18 Jan 2012
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
8 Dec 2011
Patent: 8-Triazolylxanthine Derivatives, Processes for Their Production and Their USE AS Adenosine Receptor Antagonists
7 Jul 2011
Wordmark: “lt-NES“
12 May 2011
Patent: In-Vivo Stimulations-Messsonde
31 Mar 2011
Patent: 8-Triazolylxanthine Derivatives, Processes for Their Production and Their use as Adenosine Receptor Antagonists
16 Dec 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
28 Oct 2010
Patent: In-Vivo Stimulation Measuring Probe
1 Jul 2010 in Fk
Public funding (€390,668): Biopharma-Neuroallianz: Human neural cell-based test system for cytopathological processes in Alzheimer's dementia - sub-projects:
2 Jun 2010
Address
1 Mar 2010 in Fts
EU funding (€7,400.26): Eurostemcell
21 Dec 2009
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
29 Oct 2009
Patent: In-Vivo Stimulations-Messsonde
15 Jun 2009
Patent: Fusion Protein and USE Thereof
24 Mar 2009
Patent: Promotion of Neuronal Integration in Neural Stem Cell Grafts
19 Dec 2008
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
25 Sept 2008
Patent: Maintenance of Hair Growth and Treatment of Hair-Loss
7 Apr 2008
Patent: Androgenetic Alopecia
17 Mar 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
9 Jan 2008
Original document: “Liste der Gesellschafter“
27 Dec 2007
Original document: “Liste der Gesellschafter“
3 Dec 2007
Authorized signatory (ppa) (1) · No longer Managing Director (1)
25 Sept 2007
Patent: Maintenance of Hair Growth and Treatment of Hair-Loss
23 Jul 2007
Annual report for the year ending 31/12/2005
24 Apr 2006
Patent: Methods for Identifying Modulators of CB1 and CB2 Cannabinoid Receptors and Their USE in Wound Healing
27 Mar 2006
Managing Director (1)
19 Sept 2005
Managing Director (1)
10 Aug 2005
Wordmark: “SmartCells“
1 Jul 2005 in Fk
Public funding (€148,500): Photonic Techniques for Cellular Nanosurgery - Sub-Projects: Laser-assisted Purification and Transfection of Stem and Precursor Cells
27 May 2004
No longer Managing Director (1)
16 Sept 2002
Managing Director: Christoph O. Brüstle
5 Sept 2002
Reg­is­tra­tion · MD (2) · Capital: €100,000 · Seat: Bonn · Legal form · Name: Life & Brain GmbH · Proxy policy · Is the research of diseases of the nervous system and other organs as well as the …
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Life & Brain GmbH, Bonn, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.